Phosphorus-32 for intractable pain in carcinoma of prostate. Analysis of androgen priming, parathormone rebound, and combination therapy

Urology

Volumn 9, Issue 2, 1977, Pages 137-139

  Johnson, D E ^a   Haynie, T P ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; PARATHYROID HORMONE; PHOSPHORUS 32; RADIOISOTOPE; TESTOSTERONE CIPIONATE;

BONE METASTASIS; DRUG MIXTURE; DRUG THERAPY; ESTROGEN THERAPY; METASTASIS; PAIN; PROSTATE CARCINOMA; THERAPY;

AGED; BONE NEOPLASMS; DRUG THERAPY, COMBINATION; HUMAN; MALE; MIDDLE AGE; NEOPLASM METASTASIS; PAIN, INTRACTABLE; PALLIATIVE CARE; PARATHYROID HORMONES; PHOSPHORUS RADIOISOTOPES; PROSTATIC NEOPLASMS; TESTOSTERONE;

EID: 0017329164     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/0090-4295(77)90182-0     Document Type: Article

References (8)

1. Radioactive isotopes and nuclear radiations in treatment of cancer
2. The use of radioactive phosphorus and testosterone in metastatic bone lesions from breast and prostate
3. The treatment of bone metastases with parathormone followed by radiophosphorus
4. 32P therapy in prostatic cancer with bone metastases
5. Testosterone potentiated with radiophosphorus therapy of osseous metastases in prostatic cancer
6. Phosphorus 32 for intractable pain in carcinoma of the prostate
7. Experiences with P-32 in advanced carcinoma of the prostate
8. Management of primary and metastatic carcinoma of the prostate by the radiotherapist